No one's disease is exactly the same, neither are treatment goals, access, or financial ability. We believe current research tells us that expert excision of lesions is the gold standard treatment for endometriosis and this often includes the use of hormones post surgery (though not all) - however, we also believe in supporting each other wherever we are on the journey to pain-free living. For a more in-depth description of endometriosis (or "endo"), please check out this article by the Center for Endometriosis Care. This tissue builds up and responds to the hormones produced by the body and it typically results in pain. 2014 3:475–479.Endometriosis is a condition where tissue similar to the endometrial tissue found in the uterus implants and develops outside of the uterus, typically on adjacent structures such as the ovaries, intestines, and bladder. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ETTL. Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. 2011 60:1327–1335.īutton LA, Roberts SE, Evans PA, Goldacre MJ, Akbari A, Dsilva R, Macey S, Williams JG. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Lanas A, García-Rodríguez LA, Polo-Tomás M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, Perez-Gisbert J, Bujanda L, Castro M, Muñoz M, Rodrigo L, Calvet X, Del-Pino D, Garcia S. HS was more frequently applied for upper GI bleeding ( P = 0.04).īoth HP allow for effective hemostasis with no differences in ST, LT success and re-bleeding.Įndoclot Gastrointestinal bleeding Haemostasis Hemospray Hemostatic powder. As a primary hemostatic therapy, ST and LT success were 82% and 69%, with re-bleeding occurring in 22%. In 72 patients (47%), HP was applied as a salvage hemostatic therapy, here ST and LT success were 81% and 64%, with re-bleeding in 32%. Re-bleeding occurred in 27% of all patients. Overall ST success was achieved in 125 patients (81%) and LT success in 81 patients (67%). Majority of applications were in upper GI tract (89%) with following bleeding sources: peptic ulcer disease (35%), esophageal varices (7%), tumor bleeding (11.7%), reflux esophagitis (8.7%), diffuse bleeding and erosions (15.3%). Patients were followed up for 1 mo (mean follow-up: 3.2 mo). HP was applied in 154 consecutive patients (mean age 67 years) with GI bleeding. To analyze short term (ST-within 72 h-) and long-term (LT-within 30 d-) success for achieving hemostasis with HP and to directly compare the two agents Hemospray (HS) and Endoclot (EC). For refractory cases, hemostatic powders (HP) represent "touch-free" agents. Gastrointestinal (GI) bleeding is a common indication for endoscopy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |